Global Neurovascular Devices Market Press Release

1. GlobalNeurovascularDevicesMarkettobePropelledbytheLargePresence of Neurologic Disorders, Growth of Geriatric Population, and Rising Cases ofHypertension by CAGR of~6%During 2023 – 2033 KennethResearchpublished areporttitled“NeurovascularDevices Market:Global Demand Analysis & Opportunity Outlook 2033” which delivers detailed overview of the globalneurovasculardevices marketintermsof marketsegmentation byproduct, therapeutic application,process,end-userandbyregion. Further,for thein-depthanalysis, thereportencompasses theindustry growth indicators,restraints,supplyanddemandrisk,alongwithdetaileddiscussiononcurrent and future markettrends thatareassociated withthegrowthofthemarket. Theglobalneurovasculardevicesmarketisexpectedtoholdarevenueof~USD5billion by 2033, growing from ~USD 3 billion in 2022. The market growth can be attributed to theconsiderablepresenceofneurologicdiseases,thegrowinggeriatricpopulation,an

2. increaseinthenumberofpeoplesufferingfromhypertensionandhighcholesterollevels, alcoholabuse,anda riseinneurologicalcomplexitiesrelated to COVID-19. TheglobalneurovasculardevicesmarketisexpectedtogrowataCAGRofapproximately 6%from2023-2033.Themarketissegmentedbytherapeuticapplicationsintoischemic strokes, cerebral aneurysms, carotid artery stenosis, arteriovenous malformations and fistulas, and other diseases. Among these, the ischemic stroke segment is anticipated to hold the largest market share by the end of 2033, owing to the prevalence of stroke and other factors leading to a neurological condition, including obesity, poor mental health, andthe practiceofan unhealthylifestyle. For more description@https://www.kennethresearch.com/report- details/neurovascular-devices-market/10328957 The global neurovascular devices market is divided into five major regions, including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The marketinNorthAmericaisprojectedtoholdthelargestmarketsharebytheendof2033, backed by the increased cases of neurovascular diseases and factors like hypertension, obesity,smoking,and aging. The research is global in nature and covers detailed analysis on the market in North America(U.S.,Canada),Europe(U.K.,Germany,France,Italy,Spain,Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest ofLatinAmerica),Asia-Pacific(China,India,Japan,SouthKorea,Indonesia,Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth&opportunityanalysis,marketplayers’competitivestudy,investment opportunities,demandforfutureoutlooketc.hasalsobeencoveredanddisplayedinthe researchreport. SteadyGrowthofGeriatricPopulationtoBoosttheMarketGrowth

3. People aged 65 and above comprised about 9% of the world population in 2020. Aging bringsabout geneticvariationsleading toseveral neurologicaldisorders. The natural changes happening to the brain and central nervous system, including the lossof nervecellsandthinningof bloodvesselwalls,leadtomanyneurological conditionslikestrokes,Alzheimer'sdisease,neuropathy,brainaneurysm, and Parkinson'sdisease.Further, thedeteriorationof thenervoussystemwithaging quickens when accompanied by other health conditions like hypertension, diabetes, and highcholesterollevels.Thus,thegrowthoftheagingpopulation,alongwiththeincrease in comorbidities,callsforrobust neurovasculartreatmentfacilities. However, highexpenses relatedtothemanufacturing andimplementationof neurovasculardevices,lackofneurospecialists,keyplayersfacingunsupportive regulations, and reforms from governments are expected to operate as key restraint to the growthofglobalneurovascular devicesmarketovertheforecastperiod. This report also provides the existing competitive scenario of some of the key players of theglobalneurovasculardevicesmarketwhichincludescompanyprofilingofMedtronic, Johnson & Johnson Services, Inc., Penumbra, Inc., MicroPort Scientific Corporation., Stryker,TerumoCorporation,KANEKACORPORATION,IntegerHoldings Corporation, Perflow Medical Ltd., phenox GmbH, and others. The profiling enfolds key informationof thecompanieswhich encompassesbusinessoverview,products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of theglobal neurovascular devices market that will help industryconsultants,equipmentmanufacturers,existingplayerssearchingfor expansion opportunities, new players searching possibilities and other stakeholders to aligntheirmarketcentricstrategiesaccordingtotheongoingandexpectedtrendsinthe future. RequestReport Sample@https://www.kennethresearch.com/sample-request- 10328957

4. Kenneth Researchisaleading serviceproviderfor strategicmarketresearchand consulting. We aim to provide unbiased, unparalleled market insights and industry analysistohelpindustries,conglomeratesandexecutivestotakewisedecisionsfortheir future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order toavoid futureuncertainties. ContactformoreInfo: AJDaniel Email:sales@kennethresearch.com U.S. Phone:+13134620609